Literature DB >> 27474493

Plant-produced Crimean-Congo haemorrhagic fever virus nucleoprotein for use in indirect ELISA.

Richard Atkinson1, Felicity Burt2, Edward P Rybicki3, Ann E Meyers4.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is a disease of serious public concern caused by the CCHF virus (CCHFV). Anti-CCHFV IgG in humans can be detected using ELISA with native antigen prepared from cell cultures which have been infected with virus or from brain tissue of suckling mice which have been inoculated with virus. However, the preparation of these reagents requires high biosafety levels and is expensive. A safer, more cost-effective recombinantly-produced NP reagent is desirable. Recently, plants have been shown to be a cost-effective and safe system for expression of recombinant proteins. This work describes cloning of the CCHFV NP gene into three different plant expression systems and comparison of expression in Nicotiana benthamiana. The highest expressing construct was selected. Expressed NP was purified by ammonium sulphate fractionation prior to histidine affinity chromatography. Purified NP was tested in an indirect ELISA to determine if the recombinant antigen was able to detect anti-CCHFV IgG in sera from convalescent patients. Plant-produced NP detected IgG antibodies against CCHFV in 13/13 serum samples from convalescent patients and 0/13 samples collected from volunteers with no history of CCHFV infection. Results were compared with commercially available immunofluorescent assays and 100% concordance was obtained between the two assays. This suggests that a full evaluation of the plant produced NP for application as a safe recombinant is warranted.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crimean-Congo haemorrhagic fever; Nucleoprotein; Recombinant antigen

Mesh:

Substances:

Year:  2016        PMID: 27474493     DOI: 10.1016/j.jviromet.2016.07.025

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.

Authors:  Petra Emmerich; Angela Mika; Ronald von Possel; Anne Rackow; Yang Liu; Herbert Schmitz; Stephan Günther; Kurtesh Sherifi; Barie Halili; Xhevat Jakupi; Lindita Berisha; Salih Ahmeti; Christina Deschermeier
Journal:  PLoS Negl Trop Dis       Date:  2018-03-26

2.  Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.

Authors:  Sandiswa Mbewana; Ann E Meyers; Brandon Weber; Vuyokazi Mareledwane; Maryke L Ferreira; Phelix A O Majiwa; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2018-12-11       Impact factor: 2.563

3.  Purification of Crimean-Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis.

Authors:  Boniface Pongombo Lombe; Hiroko Miyamoto; Takeshi Saito; Reiko Yoshida; Rashid Manzoor; Masahiro Kajihara; Masayuki Shimojima; Shuetsu Fukushi; Shigeru Morikawa; Tomoki Yoshikawa; Takeshi Kurosu; Masayuki Saijo; Qing Tang; Justin Masumu; David Hawman; Heinz Feldmann; Ayato Takada
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

4.  Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).

Authors:  Elif Karaaslan; Nesibe Selma Çetin; Merve Kalkan-Yazıcı; Sevde Hasanoğlu; Faruk Karakeçili; Aykut Özdarendeli; Ahmet Kalkan; Ali Osman Kılıç; Mehmet Ziya Doymaz
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01

Review 5.  Integrating plant molecular farming and materials research for next-generation vaccines.

Authors:  Young Hun Chung; Derek Church; Edward C Koellhoffer; Elizabeth Osota; Sourabh Shukla; Edward P Rybicki; Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Nat Rev Mater       Date:  2021-12-06       Impact factor: 76.679

Review 6.  Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.

Authors:  Emmanuel Margolin; Wendy A Burgers; Edward D Sturrock; Marc Mendelson; Rosamund Chapman; Nicola Douglass; Anna-Lise Williamson; Edward P Rybicki
Journal:  Nat Rev Microbiol       Date:  2020-09-10       Impact factor: 60.633

7.  Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.

Authors:  Sultan Gülce-İz; Nazif Elaldı; Hüseyin Can; Esra Atalay Şahar; Muhammet Karakavuk; Aytül Gül; Gizem Örs Kumoğlu; Aysu Değirmenci Döşkaya; Adnan Yüksel Gürüz; Aykut Özdarendeli; Philip Louis Felgner; Huw Davies; Mert Döşkaya
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

Review 8.  Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.

Authors:  Wenshu He; Can Baysal; Maria Lobato Gómez; Xin Huang; Derry Alvarez; Changfu Zhu; Victoria Armario-Najera; Aamaya Blanco Perera; Pedro Cerda Bennaser; Andrea Saba-Mayoral; Guillermo Sobrino-Mengual; Ashwin Vargheese; Rita Abranches; Isabel Alexandra Abreu; Shanmugaraj Balamurugan; Ralph Bock; Johannes F Buyel; Nicolau B da Cunha; Henry Daniell; Roland Faller; André Folgado; Iyappan Gowtham; Suvi T Häkkinen; Shashi Kumar; Ramalingam Sathish Kumar; Cristiano Lacorte; George P Lomonossoff; Ines M Luís; Julian K-C Ma; Karen A McDonald; Andre Murad; Somen Nandi; Barry O'Keef; Subramanian Parthiban; Mathew J Paul; Daniel Ponndorf; Elibio Rech; Julio C M Rodrigues; Stephanie Ruf; Stefan Schillberg; Jennifer Schwestka; Priya S Shah; Rahul Singh; Eva Stoger; Richard M Twyman; Inchakalody P Varghese; Giovanni R Vianna; Gina Webster; Ruud H P Wilbers; Paul Christou; Kirsi-Marja Oksman-Caldentey; Teresa Capell
Journal:  Plant Biotechnol J       Date:  2021-07-19       Impact factor: 13.263

9.  Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.

Authors:  Boniface Pongombo Lombe; Takeshi Saito; Hiroko Miyamoto; Akina Mori-Kajihara; Masahiro Kajihara; Masayuki Saijo; Justin Masumu; Takanari Hattori; Manabu Igarashi; Ayato Takada
Journal:  Viruses       Date:  2022-03-06       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.